Journal list Promote Sponsor
Hormones and Cancer
United States · Springer US
workspace_premium Q2 — Oncology lock Subscription

Hormones and Cancer

Hormones and Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 40. It has a price of 2040 €. It has a best quartile of Q2.

ISSN: 1868-8497
Publisher: Springer US
Category: Oncology
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
NPD Q2
H-index 40
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.040 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

40

Docs (year)

0

Docs 3y

85

Total refs

0

Cites 3y

361

Citable 3y

83

Cites/Doc 2y

4.5

Ref/Doc

0.0

Immediate OA

2040 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer

View more

Updates from the Editors

View more

Challenges and Pitfalls in the Management of Parathyroid Carcinoma: 17-Year Follow-Up of a Case and Review of the Literature

View more

Cancer Stem Cells and Microenvironment in Prostate Cancer Progression

View more

Breast Cancer Stem Cells and Their Role in Resistance to Endocrine Therapy

View more

Antiestrogen Use and Survival of Women with Non-small Cell Lung Cancer in Manitoba, Canada

View more

Androgen Resistance in Female Mice Increases Susceptibility to DMBA-Induced Mammary Tumors

View more

Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice

View more

Androgen Action in Prostate Cancer

View more

Altered PTEN, ATRX, CHGA, CHGB, and TP53 Expression Are Associated with Aggressive VHL-Associated Pancreatic Neuroendocrine Tumors

View more

Alcohol Exposure In Utero Leads to Enhanced Prepubertal Mammary Development and Alterations in Mammary IGF and Estradiol Systems

View more

Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression

View more
SHOW MORE ARTICLES

Adrenal Cancer: Clinical Advances

View more

16-kDa Prolactin Reduces Angiogenesis, but Not Growth of Human Breast Cancer Tumors In Vivo

View more

A Randomized Control Trial Comparing the Efficacy of Antiandrogen Monotherapy: Flutamide vs. Bicalutamide

View more

A Bright Future for Hormones and Cancer: Farewell Comments of Dr. Carol A. Lange, Recent Past Editor-in-Chief

View more

5th International ACC Symposium: Surgical Considerations in the Treatment of Adrenocortical Carcinoma

View more

5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications

View more

5th International ACC Symposium: Introduction

View more

5th International ACC Symposium: Imaging for Diagnosis and Surveillance of Adrenal Tumors - New Advances and Reviews of Old Concepts

View more

5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype

View more

5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma

View more

5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications

View more

2-Methoxyestradiol and Disorders of Female Reproductive Tissues

View more

FAQs